Home » Stocks » CollPlant Biotechnologies

CollPlant Biotechnologies Ltd. (CLGN)

Stock Price: $9.55 USD 0.09 (0.95%)
Updated Jul 8, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 61.73M
Revenue (ttm) 2.33M
Net Income (ttm) -10.73M
Shares Out 6.47M
EPS (ttm) -1.92
PE Ratio n/a
Forward PE 12.74
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 8, 2020
Last Price $9.55
Previous Close $9.46
Change ($) 0.09
Change (%) 0.95%
Day's Open 9.75
Day's Range 9.42 - 9.66
Day's Volume 1,807
52-Week Range 3.35 - 14.55

More Stats

Market Cap 61.73M
Enterprise Value 59.51M
Earnings Date (est) Sep 18, 2020
Ex-Dividend Date n/a
Shares Outstanding 6.47M
Float 3.02M
EPS (basic) -2.04
EPS (diluted) -1.92
FCF / Share -1.24
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 2,006
Short Ratio 0.42
Short % of Float n/a
Beta 0.20
PE Ratio n/a
Forward PE 12.74
P/FCF Ratio n/a
PS Ratio 26.46
PB Ratio 8.93
Revenue 2.33M
Operating Income -7.78M
Net Income -10.73M
Free Cash Flow -8.25M
Net Cash 2.21M
Net Cash / Share 0.34
Gross Margin 18.82%
Operating Margin -333.56%
Profit Margin -459.80%
FCF Margin -353.75%
ROA -39.82%
ROE -202.97%
ROIC -90.90%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (2)

Buy 2
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$14.00*
(46.60% upside)
Low
13.0
Current: 9.55
High
15.0
Target: 14.00
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015
Revenue2.325.010.460.08-
Revenue Growth-53.77%982.94%470.37%--
Gross Profit0.443.360.420.08-
Operating Income-7.63-4.25-5.96-7.66-5.23
Net Income-11.16-6.25-6.05-7.75-5.18
Shares Outstanding4.994.382.660.560.47
Earnings Per Share-2.23-1.43-2.27-3.89-3.06
Operating Cash Flow-5.70-1.22-4.97-5.38-4.03
Capital Expenditures-1.46-0.83-0.13-0.14-0.39
Free Cash Flow-7.16-2.05-5.09-5.52-4.42
Cash & Equivalents3.795.354.951.060.00
Total Debt3.620.043.51--
Net Cash / Debt0.175.311.441.060.00
Assets10.758.757.804.01-
Liabilities6.663.335.272.58-
Book Value4.095.422.531.43-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name CollPlant Biotechnologies Ltd.
Country Israel
Employees 38
CEO Yehiel Tal

Stock Information

Ticker Symbol CLGN
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: CLGN

Description

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bio-printing of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. The company's products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. Its products include BioInks for 3D printing of tissues and organs; dermal filler for treating wrinkles; 3D Bioprinted breast implants; VergenixSTR, a soft tissue repair matrix intended for treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.